AlphaOS

Intelligence coverage: 55%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

PRLD

Prelude Therapeutics Inc

$4.31Sep 23, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Prelude Therapeutics Inc shows accelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

PRLD's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on PRLD.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Prelude Therapeutics Inc (PRLD) — events, not interpretation.

Event
Last session September 23, 2026 at $4.31.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Prelude Therapeutics Inc (PRLD)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for Prelude Therapeutics Inc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:
$343.95M
Revenue:
$12.14M

PRLD earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Prelude Therapeutics Inc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.